Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA clears Precision's Synchro neurovascular guidewires:

This article was originally published in Clinica

Executive Summary

Precision Vascular has CE-marked for sale in Europe its Synchro neurovascular guidewire. The West Valley City, Utah company claims that the product has 50-100 times more torque delivery at the tip of the device compared with conventional guidewires. This enhances the introduction and delivery of adjunctive devices and shortens treatment time for conditions such as aneurysms, arteriovenous malformations and strokes, it says. The Synchro product line was cleared for sale in the US last month.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT070776

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel